BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21970599)

  • 1. Sildenafil improves epicenter vascular perfusion but not hindlimb functional recovery after contusive spinal cord injury in mice.
    Myers SA; DeVries WH; Gruenthal MJ; Andres KR; Hagg T; Whittemore SR
    J Neurotrauma; 2012 Feb; 29(3):528-38. PubMed ID: 21970599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphodiesterase 5 inhibition attenuates cerebral vasospasm and improves functional recovery after experimental subarachnoid hemorrhage.
    Han BH; Vellimana AK; Zhou ML; Milner E; Zipfel GJ
    Neurosurgery; 2012 Jan; 70(1):178-86; discussion 186-7. PubMed ID: 21796010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunction.
    Corbin JD; Francis SH; Webb DJ
    Urology; 2002 Sep; 60(2 Suppl 2):4-11. PubMed ID: 12414329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphodiesterase 5 (PDE5) inhibition, ANP and NO rapidly reduce epididymal duct contractions, but long-term PDE5 inhibition in vivo does not.
    Mietens A; Tasch S; Feuerstacke C; Eichner G; Volkmann J; Schermuly RT; Grimminger F; Müller D; Middendorff R
    Mol Cell Endocrinol; 2012 Feb; 349(2):145-53. PubMed ID: 21996373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antenatal sildenafil treatment attenuates pulmonary hypertension in experimental congenital diaphragmatic hernia.
    Luong C; Rey-Perra J; Vadivel A; Gilmour G; Sauve Y; Koonen D; Walker D; Todd KG; Gressens P; Kassiri Z; Nadeem K; Morgan B; Eaton F; Dyck JR; Archer SL; Thébaud B
    Circulation; 2011 May; 123(19):2120-31. PubMed ID: 21537000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional recovery in aged and young rats after embolic stroke: treatment with a phosphodiesterase type 5 inhibitor.
    Zhang L; Zhang RL; Wang Y; Zhang C; Zhang ZG; Meng H; Chopp M
    Stroke; 2005 Apr; 36(4):847-52. PubMed ID: 15746452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sildenafil (Viagra) induces neurogenesis and promotes functional recovery after stroke in rats.
    Zhang R; Wang Y; Zhang L; Zhang Z; Tsang W; Lu M; Zhang L; Chopp M
    Stroke; 2002 Nov; 33(11):2675-80. PubMed ID: 12411660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway.
    Sahara M; Sata M; Morita T; Nakajima T; Hirata Y; Nagai R
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1315-24. PubMed ID: 20413734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of the pro-apoptotic endoplasmic reticulum stress response effector CHOP does not result in improved locomotor function after severe contusive spinal cord injury.
    Ohri SS; Maddie MA; Zhang Y; Shields CB; Hetman M; Whittemore SR
    J Neurotrauma; 2012 Feb; 29(3):579-88. PubMed ID: 21933012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct allostery induced in the cyclic GMP-binding, cyclic GMP-specific phosphodiesterase (PDE5) by cyclic GMP, sildenafil, and metal ions.
    Biswas KH; Visweswariah SS
    J Biol Chem; 2011 Mar; 286(10):8545-8554. PubMed ID: 21193396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender-specific immunological effects of the phosphodiesterase 5 inhibitor sildenafil in healthy mice.
    Karakhanova S; Yang Y; Link J; Soltek S; von Ahn K; Umansky V; Werner J; Bazhin AV
    Mol Immunol; 2013 Dec; 56(4):649-59. PubMed ID: 23911424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphodiesterase-5 is a therapeutic target for peripheral neuropathy in diabetic mice.
    Wang L; Chopp M; Szalad A; Liu Z; Bolz M; Alvarez FM; Lu M; Zhang L; Cui Y; Zhang RL; Zhang ZG
    Neuroscience; 2011 Oct; 193():399-410. PubMed ID: 21820491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of phosphodiesterase type 5 in the spinal cord and its involvement in bladder outflow obstruction related bladder overactivity.
    Füllhase C; Hennenberg M; Giese A; Schmidt M; Strittmatter F; Soler R; Gratzke C; Andersson KE; Stief C
    J Urol; 2013 Oct; 190(4):1430-5. PubMed ID: 23545097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic nucleotide phosphodiesterase type 5 activity limits blood flow to hypoperfused myocardium during exercise.
    Traverse JH; Chen YJ; Du R; Bache RJ
    Circulation; 2000 Dec; 102(24):2997-3002. PubMed ID: 11113052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brief hyperoxia increases mitochondrial oxidation and increases phosphodiesterase 5 activity in fetal pulmonary artery smooth muscle cells.
    Farrow KN; Lee KJ; Perez M; Schriewer JM; Wedgwood S; Lakshminrusimha S; Smith CL; Steinhorn RH; Schumacker PT
    Antioxid Redox Signal; 2012 Aug; 17(3):460-70. PubMed ID: 22229392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sildenafil, a phosphodiesterase type 5 inhibitor, reduces antidepressant-like activity of paroxetine in the forced swim test in mice.
    Socała K; Nieoczym D; Wyska E; Poleszak E; Wlaź P
    Pharmacol Rep; 2012; 64(5):1259-66. PubMed ID: 23238482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects and mechanisms of action of sildenafil citrate in human chorionic arteries.
    Maharaj CH; O'Toole D; Lynch T; Carney J; Jarman J; Higgins BD; Morrison JJ; Laffey JG
    Reprod Biol Endocrinol; 2009 Apr; 7():34. PubMed ID: 19389232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced NO-cGMP signaling contributes to vascular inflammation and insulin resistance induced by high-fat feeding.
    Rizzo NO; Maloney E; Pham M; Luttrell I; Wessells H; Tateya S; Daum G; Handa P; Schwartz MW; Kim F
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):758-65. PubMed ID: 20093624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy.
    Percival JM; Whitehead NP; Adams ME; Adamo CM; Beavo JA; Froehner SC
    J Pathol; 2012 Sep; 228(1):77-87. PubMed ID: 22653783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphodiesterase 5 inhibition ameliorates angiotensin II-dependent hypertension and renal vascular dysfunction.
    Thieme M; Sivritas SH; Mergia E; Potthoff SA; Yang G; Hering L; Grave K; Hoch H; Rump LC; Stegbauer J
    Am J Physiol Renal Physiol; 2017 Mar; 312(3):F474-F481. PubMed ID: 28052870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.